{"id":"W2587200722","doi":"10.1182/blood.v124.21.1757.1757","title":"Bendamustine Plus Rituximab (BR) in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma of a Phase 2 Study: Multivariate Analysis and Updated Final Results By Subgroup","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Bendamustine; Medicine; Mantle cell lymphoma; Rituximab; Internal medicine; Tolerability; Refractory (planetary science); Progressive disease; Population; Salvage therapy; Phases of clinical research; Gastroenterology; Lymphoma; Surgery; Oncology; Adverse effect; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007788632,0.001567727,0.002767179,0.0008383552,0.0002852774,0.001463503,0.001034108,0.0004917725,0.001575354],"category_scores_gemma":[0.003964124,0.0003703024,0.006821105,0.001063734,0.0003592707,0.001019949,0.000902297,0.001352833,0.0001741751],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000500107,"about_ca_system_score_gemma":0.0009683214,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001093378,"about_ca_topic_score_gemma":0.001041615,"domain_scores_codex":[0.9962044,0.002256001,0.0002293606,0.0005828199,0.0004711437,0.0002562851],"domain_scores_gemma":[0.9969688,0.001522593,0.0005320496,0.0003655353,0.0001889143,0.0004220855],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2760964,0.001512939,0.5912847,0.0007025899,0.07881539,0.0004803821,0.0002308601,0.005610714,0.008779086,0.0002565671,0.002775576,0.03345487],"study_design_scores_gemma":[0.02122015,0.03022163,0.8487824,0.0001028316,0.05675842,0.0008737395,0.0004736114,0.03419911,0.002870806,0.0007754913,0.003551933,0.0001699091],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949213,0.002336126,0.001110322,0.0001655278,0.00005283925,0.0001452342,0.0008610612,0.00003138023,0.0003761484],"genre_scores_gemma":[0.9961521,0.0004479558,0.0009928448,0.00007457603,0.00009067679,0.0001682444,0.001754573,0.00003085434,0.0002880889],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007788632,"threshold_uncertainty_score":0.04119068,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01651034400250191,"score_gpt":0.2781159732335775,"score_spread":0.2616056292310756,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}